CXCL12 and endothelial dysfunction: Previous studies demonstrate that endothelial cell-derived CXCL12 promotes atherosclerosis progression30 and our findings support that CXCL12 induces endothelial dysfunction likely through the EndoMT, a manifestation that is prevented by senolytic treatment.